CASI Pharmaceuticals Inc. (NASDAQ: CASI) Stock Information | RedChip

CASI Pharmaceuticals Inc. (NASDAQ: CASI)


$2.7500
+0.1000 ( +1.10% ) 76.9K

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Market Data


Open


$2.7500

Previous close


$2.6500

Volume


76.9K

Market cap


$40.97M

Day range


$2.6450 - $2.8990

52 week range


$2.0500 - $8.1900

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 1 Dec 16, 2024
6-k Form 6-K 3 Nov 15, 2024
6-k Form 6-K 1 Sep 12, 2024
6-k Form 6-K 3 Aug 16, 2024
6-k Form 6-K 1 Jul 19, 2024
6-k Form 6-K 3 Jul 08, 2024
6-k Form 6-K 3 Jun 27, 2024
6-k Form 6-K 3 Jun 27, 2024
6-k Form 6-K 3 May 15, 2024
6-k Form 6-K 1 Apr 08, 2024

Latest News